A hot issue in natural litigation at the moment is the question of whether cases alleging "natural" labeling deception should be stayed until FDA has had opportunity to establish policy in the area, following the agency's request for public feedback in late 2015.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?